A Promising Breakthrough for Triple‐Negative Breast Cancer by Targeting the AKT and EZH2

Authors

Xinghua Long
Zheng Liu (ORCID: https://orcid.org/0000-0002-4168-6702)
Yirong Li (ORCID: https://orcid.org/0000-0002-7493-045X)

Institutions

Wuhan University (CN)
Zhongnan Hospital of Wuhan University (CN)

Publication Details

Journal: MedComm
Published: 2025-08-01
DOI: https://doi.org/10.1002/mco2.70318
Primary Topic: Epigenetics and DNA Methylation
Type: article
Field-Weighted Citation Impact: 0.00

Funders

National Natural Science Foundation of China
Wuhan University
Zhongnan Hospital of Wuhan University

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

A Promising Breakthrough for Triple‐Negative Breast Cancer by Targeting the AKT and EZH2

Xinghua Long, Zheng Liu, Yirong Li

Aug 1, 2025

MedComm

Epigenetics and DNA Methylation

article

A Promising Breakthrough for Triple‐Negative Breast Cancer by Targeting the AKT and EZH2

Xinghua Long, Zheng Liu, Yirong Li

August 1, 2025article en

Abstract

No abstract available for this paper.

MedCommVol. 6(8)

Wuhan University (CN), Zhongnan Hospital of Wuhan University (CN)

National Natural Science Foundation of China, Wuhan University, Zhongnan Hospital of Wuhan University

Openalex Percentile: Top 82%

Epigenetics and DNA Methylation

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Promising Breakthrough for Triple‐Negative Breast Cancer by Targeting the AKT and EZH2 — Xinghua Long, Zheng Liu, et al. · MedComm (2025) | TGRS Research Map | TGRS